Giovanna Mallucci

British neuroscientist

Giovanna Mallucci speaking at Congreso Futuro 2019

Giovanna Mallucci is a prominent British neuroscientist known for her pioneering research in the field of neurodegenerative diseases. She has made significant contributions to understanding the mechanisms of neurodegeneration and has been instrumental in developing potential therapeutic strategies for conditions such as Alzheimer's disease and prion diseases.

Early Life and Education

Giovanna Mallucci was born in the United Kingdom. She pursued her undergraduate studies in medicine at the University of Oxford, where she developed a keen interest in neuroscience. Following her medical degree, she completed a PhD in neurobiology at the University of London, focusing on the molecular mechanisms underlying neurodegenerative disorders.

Career

Mallucci began her career as a clinical neurologist, working with patients suffering from various neurodegenerative conditions. Her clinical experiences fueled her research interests, leading her to transition into a full-time research role. She held a position at the Medical Research Council (MRC) Laboratory of Molecular Biology in Cambridge, where she conducted groundbreaking research on prion diseases.

In 2018, Mallucci was appointed as the Associate Director of the UK Dementia Research Institute at the University of Cambridge. Her work at the institute focuses on identifying novel therapeutic targets for neurodegenerative diseases and translating these findings into clinical applications.

Research Contributions

Mallucci's research has significantly advanced the understanding of the cellular and molecular processes involved in neurodegeneration. One of her notable contributions is the discovery of the role of the unfolded protein response (UPR) in neurodegenerative diseases. Her work demonstrated that modulating the UPR could protect neurons from degeneration, offering a potential therapeutic avenue for diseases like Alzheimer's.

She has also been involved in research exploring the use of small molecules to inhibit the pathways leading to neuronal death. Her studies have shown promise in preclinical models, paving the way for future clinical trials.

Awards and Honors

Throughout her career, Mallucci has received numerous accolades for her contributions to neuroscience. She has been elected a Fellow of the Academy of Medical Sciences and has received awards from various scientific organizations recognizing her innovative research.

Related Pages

• Neurodegenerative disease
• Alzheimer's disease
• Prion disease
• University of Cambridge
• Medical Research Council